Ocular immunology and inflammation
-
Ocul. Immunol. Inflamm. · Dec 2013
Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.
To assess long-term efficacy and safety of infliximab for refractory Behçet disease (BD) uveitis and to evaluate the effect of withdrawal of infliximab after achieving long-term remission. ⋯ Infliximab is effective and safe for long-term treatment for refractory BD uveitis. Repeated infusions are required to maintain long-term remission, which may be sustained despite withdrawal of infliximab. Induction of autoantibodies is common.